Indicators
Indicators
Value
Direction
MACD(12,26,9)
-1.479
Neutral
RSI(14)
66.603
Neutral
STOCH(KDJ)(9,3,3)
69.298
Neutral
ATR(14)
5.495
Low Volatility
CCI(14)
83.413
Neutral
Williams %R
22.754
Buy
TRIX(12,20)
0.403
Sell
StochRSI(14)
33.180
Sell
Search
DaVita Inc
DVAAdd to Watchlist
240.090USD
+1.260+0.53%
Close 07-31 16:00（ET）Quotes delayed by 15 min
16.46BMarket Cap
21.95P/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
+0.53%
5 Days
+1.98%
1 Month
+7.92%
6 Months
+119.58%
Year to Date
+111.33%
1 Year
+71.04%
Key Figures
237.810Open
240.910High
426.61KVolume
21.95P/E TTM
16.16P/E Dynamic
--Dividend TTM
0.62%Turnover Ratio
238.860Prev. Close
236.085Low
44.26MTurnover
17.58P/E Static
-25.28P/B
0.00%Div Yield TTM
6.33%ROA
202.69052wk High
0.74Volume Ratio
936.34MNet Profit
68.55MShares
10.9395EPS TTM
0.90Beta
635.30%ROE
101.00052wk Low
2.02%Amplitude
26.22%Gross Margin
16.46BMarket Cap
0.88Reward/Risk
1.91%Risk Rate
TradingKey Stock Score of DaVita Inc
Currency: USD Updated: 2026-07-31Key Insights
DaVita Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 28 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 208.59.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
DaVita Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
7°C
Very Low
Very High
Neutral
DaVita Inc Highlights
StrengthsRisks
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
Overvalued
The company’s latest PE is 21.95, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 36.02M shares, decreasing 8.30% quarter-over-quarter.
Held by Warren Buffett
Star Investor Warren Buffett holds 23.75M shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.16.
Analyst Rating
Based on
9
analysts
Hold
Current Rating
208.587
Target Price
-13.43%
Upside Space
DaVita Inc News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
9
analysts
Hold
Current Rating
208.587
Target Price
-13.43%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
58
Total
9
Median
10
Average
Company name
Ratings
Analysts
DaVita Inc
DVA
9
CVS Health Corp
CVS
29
Teladoc Health Inc
TDOC
27
HCA Healthcare Inc
HCA
26
Natera Inc
NTRA
24
Tenet Healthcare Corp
THC
23
1
2
3
...
12
Indicators
Moving Average
Indicators
Value
Direction
MA5
239.136
Buy
MA10
236.885
Buy
MA20
235.123
Buy
MA50
216.864
Buy
MA100
188.652
Buy
MA200
156.649
Buy
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
DaVita Inc Info
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
Ticker SymbolDVA
CompanyDaVita Inc
CEORodriguez (Javier J)
Websitehttps://www.davita.com/
Shareholders
Related Instruments
-1.72%
-0.43%
+0.12%
-0.59%
-0.74%
+0.10%
-6.42%
-0.36%
+1.75%
-0.14%
-2.99%
+1.58%
-0.29%
-1.02%
+0.13%
+0.05%
-0.80%
-0.24%
-0.70%
-0.78%Popular Instruments
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4041.430
-61.400 (-1.50%)
FAQs
What is the current price of DaVita Inc (DVA)?
The current price of DaVita Inc (DVA) is 240.23.
What is the symbol of DaVita Inc?
The ticker symbol of DaVita Inc is DVA.
What is the 52-week high of DaVita Inc?
The 52-week high of DaVita Inc is 202.69.
What is the 52-week low of DaVita Inc?
The 52-week low of DaVita Inc is 101.00.
What is the market capitalization of DaVita Inc?
The market capitalization of DaVita Inc is 16.47B.
Is DaVita Inc (DVA) currently rated as Buy, Hold, or Sell?
According to analysts, DaVita Inc (DVA) has an overall rating of signal_hold, with a price target of 208.59.
What is the Earnings Per Share (EPS TTM) of DaVita Inc (DVA)?
The Earnings Per Share (EPS TTM) of DaVita Inc (DVA) is 10.06.